Modern management of diabetic foot osteomyelitis. The when, how and why of conservative approaches.
Javier Aragón-SánchezBenjamin A LipskyPublished in: Expert review of anti-infective therapy (2017)
Diabetic foot osteomyelitis (DFO) has long been considered a complex infection that is both difficult to diagnose and treat, and is associated with a high rate of relapse and limb loss. Areas covered: DFO can usually be diagnosed by a combination of clinical evaluation, serum inflammatory markers and plain X-ray. When the results of these procedures are negative or contradictory, advanced imaging tests or bone biopsy may be necessary. Staphylococcus aureus remains the most frequent microorganism isolated from bone specimens, but infection is often polymicrobial. Antibiotic therapy, preferably with oral agents guided by results of bone culture, for a duration of no more than six weeks, appears to be as safe and effective as surgery in cases of uncomplicated forefoot DFO. Surgery (which should be limb-sparing when possible) is always required for DFO accompanied by necrotizing fasciitis, deep abscess, gangrene or in cases not responding (either clinically or radiographically) to apparently appropriate antibiotic treatment. Expert commentary: Research in the past decade has improved diagnosis and treatment of DFO, and most cases can now be managed with a 'conservative' approach, defined as treatment either exclusively with antibiotics or with surgery removing as little bone and soft tissue as necessary.
Keyphrases
- soft tissue
- minimally invasive
- bone mineral density
- coronary artery bypass
- staphylococcus aureus
- clinical evaluation
- bone loss
- surgical site infection
- bone regeneration
- postmenopausal women
- body composition
- magnetic resonance
- magnetic resonance imaging
- coronary artery disease
- cystic fibrosis
- preterm birth
- biofilm formation
- cell therapy